Currently, there are 124.10M common shares owned by the public and among those 120.79M shares have been available to trade.
The company’s stock has a 5-day price change of 31.90% and 49.83% over the past three months. DOCS shares are trading 26.96% year to date (YTD), with the 12-month market performance up to 40.71% higher. It has a 12-month low price of $19.71 and touched a high of $31.86 over the same period. DOCS has an average intraday trading volume of 1.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 28.55%, 27.64%, and 33.55% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Doximity Inc (NYSE: DOCS) shares accounts for 60.36% of the company’s 124.10M shares outstanding.
It has a market capitalization of $6.61B and a beta (3y monthly) value of 1.23. The stock’s trailing 12-month PE ratio is 44.76, while the earnings-per-share (ttm) stands at $0.80. The company has a PEG of 4.52 and a Quick Ratio of 6.69 with the debt-to-equity ratio at 0.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.96% over the week and 3.77% over the month.
Earnings per share for the fiscal year are expected to increase by 9.43%, and 6.75% over the next financial year. EPS should shrink at an annualized rate of 9.90% over the next five years, compared to 193.38% over the past 5-year period.
Looking at the support for the DOCS, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on August 09, 2024, with the firm’s price target at $38. Wells Fargo coverage for the Doximity Inc (DOCS) stock in a research note released on July 18, 2024 offered a Underweight rating with a price target of $19. JP Morgan was of a view on April 25, 2024 that the stock is Neutral, while Leerink Partners gave the stock Market Perform rating on February 26, 2024, issuing a price target of $32. Barclays on their part issued Equal Weight rating on January 03, 2024.
